A8732 Prognostic performance of multiple biomarkers in the context of conventional risk factors in patients with coronary artery disease

    loading  Checking for direct PDF access through Ovid



We evaluated the ability of 8 biomarkers representing distinct pathophysiological pathways related to cardiovascular events in coronary artery disease.


We measured 8 biomarkers representing inflammation (growth differentiation factor-15 [GDF-15], fibrinogen), renal function (creatinine), endothelial activation (uric acid [UA]), cardiovascular stress (N-terminal-pro-B-type natriuretic peptide [NT-proBNP], soluble ST2 [sST2]), plaque instability (pregnancy-associated plasma protein A [PAPP-A]), and activated coagulation (D-dimer) in 3440 patients with coronary artery disease and assessed their association with myocardial infarction, stroke, cardiovascular death, heart failure and all cause death (clinical events, n = 419) over 2.9 years.


The strongest association with outcome in multivariable-adjusted analyses was observed for NT-proBNP (hazard ratio [HR] for one standard deviation [SD] increase 1.67, 95% confidence interval [CI] 1.55–1.8, C-index 0.824), GDF-15 (HR 1.74, 95% CI 1.52–2, C-index 0.806), fibrinogen (HR 3.83, 95% CI 2.66–5.52, C-index 0.798), UA (HR 2.7, 95% CI 1.92–3.8, C-index 0.792), D-dimer (HR 1.51, 95% CI 1.37–1.67, C-index 0.8) and creatinine (HR 2.51, 95% CI 2.1–3.01, C-index 0.8). Each of these single markers and their combination (C-index 0.835) added predictive information beyond that obtained by baseline model and led to substantial reclassification (P-integrated discrimination improvement < 0.05).


NT-proBNP, GDF-15, fibrinogen, UA, D-dimer, and creatinine are complementary prognostic biomarkers. Combination of the single markers significantly enhanced risk prediction but slightly improved the model fit. Mutimarker approach may improve identification of high-risk patients with CAD in need of more aggressive therapeutic interventions.

Related Topics

    loading  Loading Related Articles